Immediate Impact
60 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Works of Jacinta Abraham being referenced
AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial.
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jacinta Abraham | 67 | 179 | 13 | 73 | 15 | 312 | |
| Kim Vo | 72 | 47 | 5 | 60 | 14 | 294 | |
| Andrea Wahner Hendrickson | 61 | 140 | 23 | 22 | 14 | 280 | |
| Susan Lau | 32 | 60 | 57 | 57 | 23 | 358 | |
| J. Lahodny | 34 | 114 | 23 | 47 | 12 | 352 | |
| P K Buamah | 35 | 45 | 17 | 49 | 20 | 331 | |
| Diane Logan | 66 | 174 | 138 | 42 | 17 | 362 | |
| van Oosterom At | 33 | 161 | 5 | 29 | 20 | 368 | |
| Feng Liu | 63 | 148 | 10 | 40 | 18 | 256 | |
| Sherry A. Goodner | 54 | 195 | 7 | 16 | 18 | 337 | |
| J Mansi | 29 | 146 | 36 | 57 | 18 | 327 |
All Works
Loading papers...